Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Chimerix to Present at the Stifel 2017 Healthcare Conference

Posted on: 07 Nov 17

DURHAM, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H., Chief Executive Officer of Chimerix and Garrett Nichols, M.D., M.S., Chief Medical Officer of Chimerix will participate in a fireside chat at the Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at 11:45 a.m. ET at the Lotte New York Palace Hotel in New York City.

A live audio webcast of the presentation will be available on the Investor Relations section of Chimerix’s website at, where it will be archived for approximately 90 days.

About Chimerix
Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients. Chimerix's proprietary lipid conjugate technology and compound library have produced brincidofovir (BCV, CMX001); CMX157, which was licensed to ContraVir Pharmaceuticals; and a new clinical candidate, CMX521, for the treatment and prevention of norovirus.  For further information, please visit Chimerix's website,

Investor Relations:
Will O’Connor
Stern Investor Relations

Becky Vonsiatsky
W2O Group


Last updated on: 07/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.